Monday, August 31, 2026
ExploreSearch
Via News
MarketCommodities

Palladium Futures Bullish Momentum With A 5% Rise In The Last 10 Sessions

Palladium Futures Bullish Momentum With A 5% Rise In The Last 10 Sessions

(VIANEWS) - Palladium (PA) has been up by 5.12% for the last 10 sessions. At 23:53 EST on Monday, 20 March, Palladium (PA) is $1,407.50.

Volume

Today's last reported volume for Palladium is 20, 99.99% below its average volume of 5121763211.55.

Volatility

Palladium's last week, last month's, and last quarter's current intraday variation average was a negative 0.34%, a positive 0.75%, and a positive 2.21%, respectively.

Palladium's highest amplitude of average volatility was 1.86% (last week), 2.46% (last month), and 2.21% (last quarter), respectively.

News about

  • Brent crude oil to average $90 in h1 this year and fall to $80 in Q4 – danske bank. According to FXStreet on Monday, 20 March, "Economists at Danske Bank expect Brent Crude Oil to hover around the $90 mark in the first half of the year before falling to $80 in the fourth quarter."

More news about Palladium (PA).

Categories

MarketCommodities

Tags

CommodityCommoditiesFuturesPAPalladiumPrice UpCommodities Price UpCommodities Now
ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Hawkish Fed Signals at Jackson Hole Pressure Rate-Sensitive Assets
Kevin Warsh's hawkish inflation remarks at Jackson Hole, alongside a steady drumbeat of Federal Reserve testimony from Powell, Barr, Bowman and other officials on supervision, regulation and monetary policy, signal continued vigilance against inflation rather than an imminent easing cycle. Rate-sensitive and precious-metals-linked names such as SSR Mining sold off the same day, consistent with markets repricing for a firmer-for-longer policy stance.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,261 source documents archived
Query this data → isubstrate.com